The impact of type III sodium-dependent phosphate transporters (Pit 1 and Pit 2) on podocyte and kidney function
- PMID: 33738792
- DOI: 10.1002/jcp.30368
The impact of type III sodium-dependent phosphate transporters (Pit 1 and Pit 2) on podocyte and kidney function
Abstract
The sodium-dependent phosphate transporters Pit 1 and Pit 2 belong to the solute carrier 20 (SLC20) family of membrane proteins. They are ubiquitously distributed in the human body. Their crucial function is the intracellular transport of inorganic phosphate (Pi) in the form of H2 PO4- . They are one of the main elements in maintaining physiological phosphate homeostasis. Recent data have emerged that indicate novel roles of Pit 1 and Pit 2 proteins besides the well-known function of Pi transporters. These membrane proteins are believed to be precise phosphate sensors that mediate Pi-dependent intracellular signaling. They are also involved in insulin signaling and influence cellular insulin sensitivity. In diseases that are associated with hyperphosphatemia, such as diabetes and chronic kidney disease (CKD), disturbances in the function of Pit 1 and Pit 2 are observed. Phosphate transporters from the SLC20 family participate in the calcification of soft tissues, mainly blood vessels, during the course of CKD. The glomerulus and podocytes therein can also be a target of pathological calcification that damages these structures. A few studies have demonstrated the development of Pi-dependent podocyte injury that is mediated by Pit 1 and Pit 2. This paper discusses the role of Pit 1 and Pit 2 proteins in podocyte function, mainly in the context of the development of pathological calcification that disrupts permeability of the renal filtration barrier. We also describe the mechanisms that may contribute to podocyte damage by Pit 1 and Pit 2.
Keywords: Pit 1; Pit 2; diabetic nephropathy; podocytes; sodium-dependent phosphate transporters; vascular calcification.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Asada, Y. , Takayanagi, T. , Kawakami, T. , Tomatsu, E. , Masuda, A. , Yoshino, Y. , Sekiguchi-Ueda, S. , Shibata, M. , Ide, T. , Niimi, H. , Yaoita, E. , Seino, Y. , Sugimura, Y. , & Suzuki, A. (2019). Risedronate attenuates podocyte injury in phosphate transporter-overexpressing rats. International Journal of Endocrinology, 2019, 1-10. https://doi.org/10.1155/2019/4194853
-
- Azpiazu, D. , Gonzalo, S. , González-Parra, E. , Egido, J. , & Villa-Bellosta, R. (2018). Role of pyrophosphate in vascular calcification in chronic kidney disease. Nefrologia, 38(3), 250-257. https://doi.org/10.1016/j.nefroe.2018.03.003
-
- Bacic, D. , LeHir, M. , Biber, J. , Kaissling, B. , Murer, H. , & Wagner, C. A. (2006). The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney International, 69(3), 495-503. https://doi.org/10.1038/sj.ki.5000148
-
- Belmokhtar, K. , Ortillon, J. , Jaisson, S. , Massy, Z. A. , Boulagnon Rombi, C. , Doué, M. , Maurice, P. , Fritz, G. , Gillery, P. , Schmidt, A. M. , Rieu, P. , & Touré, F. (2019). Receptor for advanced glycation end products: a key molecule in the genesis of chronic kidney disease vascular calcification and a potential modulator of sodium phosphate co-transporter PIT-1 expression. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association, 34(12), 2018-2030. https://doi.org/10.1093/ndt/gfz012
-
- Bergwitz, C. , & Jüppner, H. (2010). Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annual Review of Medicine, 61(1), 91-104. https://doi.org/10.1146/annurev.med.051308.111339
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous